Advanced Search
Contact | Corporate | Help

Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study

Sponsors:
  • Medical Center of Central Georgia
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Acute Respiratory Distress Syndrome
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Tenecteplase
Enrollment:
20

Additional information about NCT00431379.


SourceSolution © 2008-2012